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Abstract  
AIM: To evaluate cardiovascular autonomic neuropathy (CAN) in type 1 Diabetics and to detect its 
relation to coronary artery calcification.  
PATIENTS AND METHODS: It is a cross sectional study included 62 diabetics and 30 controls. 
Clinical, laboratory assessment and 24 Hr holter were done for all patients and controls and 
coronary artery calcium (CAC) scoring by multisclice CT was done for all patients only. T-test, 
Mann Whitney U test, and stepwise multiple regression were used for statistical analyses.  
RESULTS: CAC score was positive in 8.1 % of patients. Heart rate variability (HRV) was 
significantly lower in diabetics. All parameters of HRV were insignificantly lower in diabetics with 
positive CAC score. Patients with microalbuminuria had a significantly lower HRV. HRV had a 
significant correlation with age of patients, duration of disease, HbA1, and Qtc in diabetics.  
CONCLUSION: Percentage of arrhythmia and early atherosclerosis is high in adolescent type 1 
diabetic patients. CAN is associated with early atherosclerosis. Cardiac autonomic neuropathy is 
associated with older age, longer duration, and poor glycemic control and microalbuminuria. 
 
 
 
 
 
 
 
Introduction 
 
The etiology of cardiac disease in patients 
with type 1 diabetes (T1D) may involve many factors, 
including accelerated coronary atherosclerosis, 
diabetic cardiomyopathy, and cardiac autonomic 
neuropathy (CAN) [1, 2]. Autonomic neuropathy is a 
common complication of T1D associated with older 
age, longer duration of diabetes, worse metabolic 
control, and the presence of microvascular and 
cardiovascular disease [3, 4]. Cardiac autonomic 
neuropathy affects the parasympathetic nervous 
system, leading to reduced heart rate variability 
(HRV). In people without diabetes, decreased HRV is 
associated with subclinical inflammation [5], arterial 
hypertension [6], and increased incidence of cardiac 
events [7].  
Among the features of diabetic autonomic 
neuropathy, CAN involvement is of special interest. 
Diabetic autonomic dysfunction, even when 
subclinical, is also associated with a high risk of 
mortality which makes its early identification clinically 
important. Cardiac dysfunction due to CAN has been 
demonstrated in diabetic patients without evidence of 
ischemic heart disease and this can increase the risk 
of sudden unexpected death [7, 8]. 
An association between CAN and carotid 
atherosclerosis, assessed by ultrasound, has been 
reported in patients with type 2 diabetes [9, 10]. 
Coronary artery calcium (CAC) is a powerful predictor 
of clinical coronary artery disease [11]. T1D patients 
demonstrate greater extent and progression of CAC 
than subjects without diabetes [7, 8, 12].  
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We are aiming to evaluate CAN in type 1 
Diabetics and to detect its relation to coronary artery 
calcification. 
 
 
Patients and Methods 
Patients 
The study included 62 patients with type 1 
diabetes mellitus (DM) among those attending to the 
endocrine clinic, National Research Centre. The 
control group consisted of 30 ages and sex matched 
healthy normal volunteers. 
Inclusion criteria: Patients with Duration of 
disease > 5 years, patients age > 14 and < 19 yrs old. 
Exclusion criteria: Patients during acute 
diabetic complications e.g. diabetic ketoacidosis 
(DKA) or hypoglycemia, patients suffering from 
cardiac diseases e.g. congenital, rheumatic heart, left 
ventricular dysfunction, patients receiving drugs for 
cardiovascular disease. 
 
Study design and protocol 
It is a prospective cross sectional study done 
after obtaining approval from the ethical committee of 
the National Research Centre, Cairo, Egypt. 
Registration number is 11052. Written informed 
consent was obtained from all patients, their parents 
and controls after full discussion about the aim of the 
study. This study is a part from a project done in the 
National Research Centre in collaboration with Cairo 
University for evaluation of cardiac, vascular and 
endothelial function in adolescent type 1 diabetic 
patients.  
All the studied patients were subjected to: 
History taking including: Age of patients, sex, 
age of onset of diabetes, duration of diabetes, type 
and dose of insulin therapy, family history of diabetes. 
We asked about presence of any symptoms of 
cardiac, renal, neurological affection or presence of 
any type of autonomic dysfunction. We also asked 
about history of taking drugs other than insulin. 
Patients and controls were subjected to 
general, cardiac, chest and neurological examination. 
 Simultaneously all patients and controls 
underwent the following tests: 
For cholesterol measurements, venous blood 
was sampled after 12 hr fast. Serum total cholesterol 
was determined by a commercial kit (Boehringer-
Mannheim, Germany). High-density lipoprotein (HDL) 
cholesterol was separated from the serum by 
precipitation of other lipoproteins with a 
heparin/manganese procedure. Low-density 
lipoprotein (LDL) cholesterol was calculated using the 
Friedewald equation. The concentration of 
triglycerides was measured in a TechnoCon 
AutoAnalyzer II (TechnoCon Instruments, Tarrytown, 
New York).  
Glycosylated hemoglobin (HbA1) was done 
every 3 months and the mean value was calculated 
per year retrospectively from files. It was measured 
using high-pressure liquid chromatography (Nichols 
Institute, Van Nuys, California). 
Screening for microalbuminuria: It was 
assessed in fresh morning urine samples by 
measuring albumin/creatinine ratio by enzyme linked 
immunosorbent assay (ELISA). 
Heart rate variability (HRV) was measured by 
computerized analysis of long term heart rate samples 
(1024 beats) using 24 hour holter monitoring space 
lab boarded in which the software automatically 
calculates all heart rate indices in a comprehensive 
and accurate form. Spectral analysis was performed 
on linearly resample (1 Hz) time series using Welch's 
method [13].  
Time domain analysis is computed on 
differing computations of the measurement of the 
standard deviation of heart period, based on sinus R-
R intervals over time [14, 15]. The time domain 
analysis of heart rate variability can be further divided 
into two categories. One category is derived from the 
R-R intervals, using means and standard deviations of 
the intervals measured in milliseconds. Measures in 
this category include the SDRR. The SDRR is the 
standard deviation of all R-R intervals during a 24-
hour period. Values for SDRR that are less than 50 
milliseconds have been associated with sudden 
cardiac death [16]. The second category of time 
domain variables is derived from differences between 
adjacent R-R intervals and includes indices that are 
independent of circadian rhythms. The PNN50 is the 
proportion of the total R-R intervals that have 
differences of successive R-R intervals greater than 
50 milliseconds. SDARR is the standard deviation 
values of all averaged normal sinus R-R intervals for 
each 5-minute segment in the 24-hour recordings. 
The RMSSD is the square root of the mean squared 
differences of successive R-R intervals. Reflecting 
alterations in autonomic function that are primarily 
vagally mediated, the RMSSD, SDRR and PNN50 
correlate highly with high-frequency power, reflecting 
parasympathetic modulation [14]. Other time-domain 
variables reflect a mixture of parasympathetic, 
sympathetic, and other physiologic influences [15, 17]. 
The end of the T wave was defined as the 
point of maximal change in the slope as the T wave 
merges with the baseline. QT interval was corrected 
for heart rate by calculating QTc. QTc was calculated 
with Bazett's equation [QTc=QT interval 
(ms)/√(60/heart rate)] [18]. 
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Assessment of coronary calcium scoring by 
multisclice CT 
CT examination was performed in one centre 
using the CT scanner; iCT 256 (Philips Medical 
Systems; Eindhoven, Netherland). The patient is 
positioned supine on the CT table. ECG leads are 
fixed at the four corners of the pericordium. All 
reconstructions are performed using the retrospective 
ECG gating. For this technique; an ECG must be 
recorded simultaneously throughout the duration of 
the scanning.  
First, a localization scan (scanogram) is 
performed that yields an antero-posterior and lateral 
views of the chest. It is used to position the imaging 
volume of the coronary arteries that extends from the 
level of the carina down to about 1 cm below 
diaphragm. The center of the field of view is 2 cm to 
the left of the dorsal spine on the AP scout and at the 
level of the hilum on the lateral scout. 
A non-contrast CT examination of the heart 
was performed for all patients in order to detect and 
quantify coronary calcifications through the volume 
extended from below the carina to the apex of the 
heart. Acquisition parameters were ECG gated at 75% 
of the RR interval, 270 ms gantry rotation, 256 x 0.625 
mm collimation, 80 mA, and 120 kV. To minimize the 
total effective patient radiation dose, this stage of the 
scanning was conducted with a relatively low tube 
current. The radiation dose of the CT coronary 
calcium score, according to this technique, is about 1 
mSv, in average. A radiologist read all computed 
tomography using an interactive scoring system 
similar to that used by Yaghoubi et al., [19]. 
 
Statistical Analysis 
Statistical analysis was conducted using 
Statistical Package for Social Science (SPSS) 
program version 15.0 (Chicago, Illinois, USA). t -test 
for independent variables was used and non 
parametric (Mann Whitney U) test was used when 
data was not symmetrically distributed. Stepwise 
multiple regression analysis was also performed to 
find an association of SDARR, SDRR, DRR, PNN50 
and RMSSD with QTc, age of patients, duration of 
disease, VLDL and HbA1c which had p value <0.05 in 
simple correlation analysis (Pearson’s or Spearman 
correlation). 
 
 
Results 
 
The study included 62 patients with type 1 
diabetes (31 males and 31 females) and 30 healthy 
volunteer (15 males and 15 females). All diabetic 
patients were on intensive insulin therapy regimen.  
Comparison between demographic, 
anthropometric and laboratory data of patients and 
controls were shown in Table 1.  
Table 1: Comparison between demographic, anthropometric 
and laboratory data of patients and controls 
Variables 
Patients Controls 
P-value Mean SD Mean SD 
Age (yrs) 16.32 1.52 16.13 2.63 0.70 
Laboratory data: 
     HbA1 (%) 9.55 1.90 5.43 0.65 0.0001 
Albumin/  creatinine ratio 
(µg/g  creatinine) 78.33 100.65 11.28 4.23 0.0001 
Total cholesterol (mg/dl) 188.81 63.77 100.54 20.41 0.0001 
Triglyceride (mg/dl) 103.46 78.29 68.89 28.39 0.03 
HDL-c (mg/dl) 51.77 20.58 52.21 11.12 0.90 
LDL-c (mg/dl) 118.66 47.53 62.50 19.88 0.0001 
HDL-c: High density lipoprotein- cholesterol; LDL-c: Low density lipoprotein – cholesterol; 
HbA1: Glycosylated haemoglobin. 
 
Average, maximum and minimum heart rate, 
SDRR, DRR, SDDRR, PNN50 and RMSSD were 
significantly lower in diabetics (Table 2). No difference 
in HRV in diabetic patients was found in relation to 
sex, P > 0.05 (data not present).  
Table 2: Comparison between parameters of 24 hr holter of 
diabetic patients and controls included in the study 
Variables Patients 
Median 
Mean ± SD 
(Interquartile range) 
N = 62 
Controls 
Median 
Mean ± SD 
(Interquartile 
range) 
N = 30 
Test 
t/Z 
P-value   
SDARR (ms) 32.0 
32.0 ± 12.1 
(24.0 – 32.0) 
33.0 
34.8 ± 10.6 
(29.0 – 43.0)) 
-2.4 0.002#   
Average HR (BPM) 90.5 ± 10.2 86.4 ± 8.0 1.85 0.04   
Maximum HR (BPM) 163.1 ± 14.8 132.6 ± 18.1 8.2 0.0001   
Minimum HR (BPM) 57.3 ± 10.4 67.9 ± 6.8 -4.9 0.0001   
Mean RR interval 611.0 ± 79.7 631.6 ± 92.6 -1.06 0.2   
Median RR interval 609.1 ± 79.6 629.4 ± 91.9 -1.05 0.3   
Standard deviation RR (SDRR) (ms) 33.5 
34.4 ± 13.4 
24.0 – 42.8) 
41.0 
46.6 ± 19.5 
38.0 – 57.0) 
-3.0 0.003#   
Mean difference RR (DRR)(ms) 22.0 
24.6 ± 11.2 
16.0 – 33.0) 
32.5 
36.1 ± 24.4 
(21.3 – 44.5) 
-2.4 0.02#   
Standard deviation difference RR 
(SDDRR)(ms) 
18.0 
37.5 ± 132.7 
(13.0- 24.8) 
27.0 
30.4 ± 20.3 
(17.3 – 38.3) 
-2.6 0.009#   
Percentage of RR > 50 msec (PNN50) 
(%) 
11.0 
11.9 ± 8.6 
(6.0- 18.0) 
17.0 
20.3 ± 16.5 
7.0- 34.8) 
-3.1 0.05#   
The square root of the mean squared 
difference of successive R- R  interval  
(RMSSD)(ms) 
27.1 
29.5 ± 15.0 
(19.0 – 40.0) 
44.0 
47.3 ± 31.6 
(28.0 – 58.0) 
3.5 0.002# 
Corrected QT interval (QTc)(ms) 381.0 ± 29.2 371.0 ± 43.8 0.47 0.6 
ST segment deviation 0.9 
1.0 ± 0.4 
(0.7 – 1.3) 
1.0 
1.0 ± 0.4 
(0.7 – 1.2) 
-0.1 0.9# 
t- independent  test. # Mann Whitney –U test. 
 
Five (8.1%) patients had positive coronary 
calcium score and 28 (41.2%) patients had 
microalbuminuria. Although all parameters of HRV 
were lower in diabetics with positive CAC score, it was 
statistically not significant (Table 3). Table 4 showed 
the arrhythmia detected by 24 hr holter of patients 
included in the study. DRR, PNN50 and RMSSD were 
significantly lower in microalbuminuric patients (Table 
5). Triglyceride had as significant positive correlation 
with minimum and maximum HR (r = 0.4, P = 0.004 
and r = 0.3, P = 0.03 respectively). Age of patients (β 
= -3.2, 95% CI: -5.4 – 1.0, p=0.006) and QTc (β= -0.1, 
95% CI: -0.2 - -0.003, p = 0.04) were related to 
SDARR by stepwise multiple regression analysis. On 
the other hand, Duration of disease (β = - 1.5, 95% CI: 
-2.6 - -0.4, p=0.01) and (β = -1.7, 95% CI: -2.9 – - 0.4, 
p=0.008) and HbA1 (β = -2.2, 95% CI: -4.0 - -0.5, p = 
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0.01) and (β = -2.5, 95% CI: -4.4 - -0.7, p = 0.009) 
were related to SDRR and RMSSD by stepwise 
multiple regression analysis respectively.  
Table 3: Comparison between parameters of 24hr Holter of 
diabetic patients in relation to coronary calcium score 
Variables Coronary calcium score 
Negative 
Median 
Mean ± SD 
(Interquartile 
range) 
N = 57 
Positive 
Median 
Mean ± SD 
(Interquartile 
range) 
N = 5 
Test 
t/Z 
P-value   
SDARR (ms) 32.0 
32.2 ± 12.7 
(22.5 – 41.0) 
35.0 
31.7 ± 6.7 
(24.0- 36.0) 
-0.04 0.9#   
Average HR (BPM) 90.3 ± 9.8 85.5 ± 11.1 0.9 0.4   
Maximum HR (BPM) 162.8 ± 14.5 160.0 ± 15.9 0.37 0.7   
Minimum HR (BPM) 57.7 ± 10.5 50.5 ± 8.4 1.34 0.9   
Mean RR interval 616.0 ± 82.5 574.5 ± 36.6 0.09 0.3   
Median RR interval 614.2 ± 82.5 572.8 ± 38.5 1.84 0.3   
Standard deviation RR 
(SDRR)(ms) 
33.5 
34.8 ± 14.0 
(24.0- 44.0) 
33.0 
31.8 ± 5.7 
(25.8 – 36.5) 
-0.3 0.7#   
Mean difference RR 
(DRR)(ms) 
22.0 
24.8 ± 11.7 
(15.0 – 33.3) 
21.8 
23.1 ± 6.7 
(17.5 – 30.1) 
-0.2 0.9#   
Standard deviation difference 
RR (SDDRR)(ms) 
18.0 
39.9 ± 140.4 
(12.5 – 25.1) 
17.5 
17.4 ± 4.2 
(13.6 – 21.0) 
-0.3 0.8#   
Percentage of RR > 50 msec 
(PNN50)(%) 
11.1 
12.2 ± 8.8 
(6.0 – 18.0) 
11.5 
11.3 ± 6.1 
(5.3 – 17.0) 
-0.2 0.9#   
The square root of the mean 
squared difference of 
successive R- R  interval  
(RMSSD) (ms) 
27.5 
30.1 ± 15.3 
(18.3 – 41.0) 
27.5 
28.8 ± 10.1 
(19.8 – 39.0) 
-0.1 0.9# 
Corrected QT interval (QTc) 
(ms) 
381.9 ± 28.6 377.0 ± 29.6 0.33 0.7 
ST segment deviation 0.9 
0.9 ± 0.4 
(0.7 – 1.3) 
1.1 
1.1 ± 0.2 
(0.9 – 1.3) 
-1.1 0.3# 
t- independent  test; # Mann Whitney –U test. 
 
DRR was related to VLDL (β = - 0.9, 95% CI: 
0.4 – 1.3, p = 0.002) and HbA1 (β = -2.2, 95% CI: -4.3 
– 0.1, p = 0.04).On the contrary, duration of disease 
(β = -1.1, 95% CI: -1.8 - -0.3, p = 0.008) was the only 
parameter related to PNN50 by stepwise multiple 
regression analysis (Table 6).  
Table 4: Arrhythmia detected by 24 hr holter of patients 
included in the study 
Variables N % 
Ventricular ectopia:   
Number 14 23.3 
Form of  ventricular ectopia:   
Isolated mono 10 71.4 
Isolated poly 4 28.6 
Supraventricular ectopia:   
Number 10 16.7 
Supraventricular tacchcardia 2 3.3 
Sinus tachycardia 1 1.6 
Exit sinus block 2 3.3 
 
No significant difference of demographic and 
anthropometric data, blood pressure, and lipid profile 
was found in diabetic patients in relation to CAC 
score.  
 
Discussion 
In the current study, average, maximum and 
minimum heart rate, SDRR, DRR, SDDRR, PNN50 
and RMSSD were significantly lower in diabetics. 
Reflecting alterations in autonomic function that are 
primarily vagally mediated, the RMSSD, SDRR and 
PNN50 correlate highly with high-frequency power, 
reflecting parasympathetic modulation [14].  
Table 5: Comparison between parameters of 24hr  holter of 
diabetic patients in relation to microalbuminuria 
Variables Microalbuminuria 
Normalbuminuria 
Median 
Mean ± SD 
(Interquartile 
range) 
N = 34 
Microalbuminuria 
Median 
Mean ± SD 
(Interquartile 
range) 
N = 28 
Test 
t/Z 
P-value   
SDARR(ms) 33.0 
34.8 ± 10.6 
(29.0 – 43.0) 
29.0 
28.6 ± 13.2 
(16.8 – 36.5) 
-1.7 0.08#   
Mean RR interval 622.2 ± 81.3 597.2 ± 77.0 1.17 0.2   
Median RR interval 619.4 ± 81.5 596.5 ± 77.1 1.07 0.3   
Standard deviation NN 
(SDRR) (ms) 
37.0 
37.4 ± 14.1 
(29.0 – 44.0) 
31.0 
(30.8 ± 11.7 
(21.0 – 37.5) 
-1.7 0.08#   
Mean difference NN (DRR) 
(ms) 
29.0 
28.1 ± 12.0 
(19.0 – 34.0) 
32.50 
20.1 ± 8.4 
(13.3 – 23.8) 
-2.5 0.01#   
Standard deviation difference 
NN (SDDRR) (ms) 
21.0 
22.2 ± 11.5 
(14.0 – 25.0) 
17.0 
56.3 ± 198.8 
(11.0 – 21.0) 
-1.7 0.09#   
Percentage of RR > 50 msec 
(PNN50) (%) 
14 
14.7 ± 9.3 
(9.0 -19.0) 
7.1 
8.4 ± 6.3 
(4.0 – 12.6) 
-2.7 0.008#   
The square root of the mean 
squared difference of 
successive R- R  interval  
(RMSSD) (ms) 
31.0 
34.5 ± 16.1 
(22.0 – 41.0) 
22.0 
23.2 ± 10.7 
(14.0 – 27.9) 
-2.9 0.003# 
Corrected QT interval (QTc) 
(ms) 
375.2 ± 29.7 388.6 ± 27.2 -1.72 0.09 
ST segment deviation 0.9 
0.9 ± 0.4 
(0.6 – 1.3) 
0.9 
1.0 ± 0.4 
(0.8 – 1.1) 
-0.6 0.6# 
t- independent  test; # Mann Whitney –U test. 
  
Within the pediatric literature, HRV (a 
measure of cardiovascular autonomic function) was 
lower in adolescents with T1DM compared to healthy 
controls [15, 20, 21] and lower in youth with T2DM 
versus T1DM [22]. Chen et al., [23], reported that, 
time domain is thought to be a marker of 
parasympathetic function, and these findings suggest 
that it can be detected early before any manifestation 
of symptoms and when conventional tests are still 
normal.  
Table 6: Stepwise multiple regression analysis of SDARR, 
SDRR, DRR, PNN50 and RMSSD in relation to demographic 
and laboratory data 
Variables Β 95% 
Confidence interval 
P-value 
SDARR:    
Constant 126.5 71.7 – 181.2 0.0001 
Age of patients (yr) - 3.2 -5.4 – 1.0 0.006 
QTc -0.1 - 0.2 - - 0.003 0.04 
R
2
 = 0.22, SEM = 11.0 
SDRR:    
Constant 69.6 48.1 – 91.1 0.0001 
Duration of disease (yr) - 1.5 -2.6 - - 0.4 0.01 
HbA1 % -2.2 -4.0 - - 0.5 0.01 
R
2
 = 0.9, SEM = 11.6 
DRR:    
Constant 28.9 11.1 – 46.8 0.004 
VLDL (mg/dl) - 0.9 - 0.4 – 1.3 0.002 
HbA1 (%) -2.2 -4.3 – 0.11 0.04 
R
2
 = 0.53, SEM = 5.5 
PNN50:    
Constant 22.0 14.3- 29.6 0.0001 
Duration of disease (yr) -1.1 -1.8 - - 0.3 0.008 
R
2
 = 0.13, SEM = 8.2 
RMSSD:    
Constant 69.5 46.2 – 92.9 0.0001 
Duration of disease (yr) -1.7 -2.9 - - 0.4 0.008 
HbA1 (%) -2.5 -4.4 - - 0.7 0.009 
R
2 
= 0.20, SEM = 12.50 
R
2
: Coefficient of determination   SEM = standard error of mean.   Dependent variables: 
SDARR, SDRR, DRR, PNN50  and RMSSD.     Independent variables: duration of 
disease, age of patients, QTc, HbA1, VLDL 
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It also suggests that parasympathetic 
autonomic dysfunction is the first abnormality to arise 
in the development of CAN [24]. Time domain 
analysis of HRV, has several advantages over 
conventional techniques. In addition to being a more 
sensitive measure of autonomic dysfunction, it is easy 
to perform with limited specialist training, does not 
require expensive and cumbersome equipment, is 
very quick to carry out, and 4) is not affected by 
subject variability [24].  
No difference in HRV was found between in 
males and females in our study. These coincide with 
the result of Rodrigues et al., [7]. The EURODIAB 
IDDM Complications Study also found no higher risk 
of CAN in women [4]. Thus, reduced HRV is not likely 
to be the basis of the more adverse effect of diabetes 
on coronary artery disease in women than in men. In 
the contrary, In the Pittsburgh Epidemiology of 
Diabetes Complications Study, women with T1D had 
higher risk of CAN than men [7, 25, 26].  
In the present study, 5 (8.1%) patients had 
positive CAC score and all parameters of HRV were 
lower in diabetics with positive CAC score, but it was 
statistically not significant. This may be related to the 
small number of diabetics and if the number increase 
it may be significant. In the contrary, Salem et al [27], 
found that 12 diabetic patients (20%) has positive 
CAC. This may be related to the selection of patients 
as they selected patients with duration of disease ≥ 10 
yr (longer duration than our patients). 
Rodrigues et al., [7], studied young patients 
with asymptomatic atherosclerosis; they suggest that 
reduced HRV could be associated with early 
atherosclerosis rather than being an effect of the 
ischemia that occurs in established coronary artery 
disease [7]. They reported that reduced HRV 
prospectively predicts progression of CAC, a powerful 
marker of cardiovascular disease risk, in patients both 
with and without T1D and independently of known 
cardiovascular disease risk factors. Although the 
association between CAN and increased 
cardiovascular mortality in patients with diabetes is 
known, silent coronary artery disease in diabetes 
appears to be related to accelerated atherosclerosis 
than to CAN [2]. However, sympathetic denervation 
may cause dedifferentiation of vascular smooth 
muscle cells [28]. These alterations are associated 
with extracellular matrix production and migration to 
the intima, changes that have been seen in 
atherosclerosis [29]. Therefore, the possibility that 
autonomic dysfunction is implicated in the 
atherosclerosis process is plausible [7]. Lower HRV 
was a predictor of CAC progression independent of 
inflammatory markers. Experimental findings suggest 
that the nervous autonomic system could significantly 
modulate inflammatory reaction [7, 30, 31]. 
In our study, fourteen (23.3%) of diabetics 
had ventricular ectopia, 10 (16.7%) patients had 
supraventricular ectopia, 2 (3.3%) patients had 
supraventricular tachycardia and 2 (3.3%) patients 
had exit sinus block. The mechanism by which 
autonomic neuropathy causes increased mortality is 
unclear. It may be that increased mortality is due to an 
increased likelihood of cardiac ventricular arrhythmia 
[32]. Several studies show that the sympathetic 
nervous system promotes cardiac arrhythmias such 
as ventricular tachycardia and ventricular fibrillation 
[33, 34]. The parasympathetic nervous system is 
believed to play a protective role, decreasing the 
likelihood of malignant arrhythmia [33, 35]. 
In the current study, 28 (41.2%) patients had 
microalbuminuria and the remaining patients were 
normoalbuminuric. DRR, PNN50 and RMSSD were 
significantly lower in microalbuminuric patients in the 
present study. A clinical association between diabetic 
autonomic neuropathy (DAN) and nephropathy in 
diabetes has been documented in some studies [7, 
36]. Hyperglycemia may be a common factor in the 
pathogenesis of these complications, and poor 
glycemic control has been demonstrated to influence 
the development of progression of both nephropathy 
and neuropathy. The association between DAN and 
nephropathy might have a pathogenetic significance 
rather than being due to the simple coexistence of the 
2 diabetic complications [23]. In the contrary, Faulkner 
et al., [15], reported no statistically significant 
associations between measures of HRV and albumin / 
creatinine ratio in adolescent’s diabetics. This may 
explain that CAN precede the occurrence of 
nephropathy [4].  
Zander et al., [37], investigated the 
prevalence of CAN in patients with insulin dependant 
diabetes mellitus at different stages of diabetic 
nephropathy and found that CAN was more prevalent 
in patients with diabetic nephropathy, more so as 
nephropathy progresses. The proposed mechanism 
by which autonomic neuropathy affecting renal 
function were modifying 24 h blood pressure profile so 
that the relatively higher nocturnal blood pressure 
values cause an increase albumin excretion rate 
during the night, impairment of renal sympathetic 
innervation play a role in hemodynamic alterations 
involved in the early stages of diabetic nephropathy 
and albuminuria [8].  
In the current study, triglyceride had a s 
significant positive correlation with minimum and 
maximum HR (r = 0.4, P = 0.004 and r = 0.3, P = 0.03 
respectively). This indicates that hyperlipidemia may 
lead to affection of heart rate which is an early signs 
of cardiac autonomic neuropathy. The Pittsburgh 
Epidemiology of Diabetes Complications Study III [25] 
found on multivariate analysis that increased LDL 
cholesterol levels and decreased HDL levels were 
independently associated with the presence of 
autonomic neuropathy in 168 subjects with insulin-
dependent diabetes mellitus. In diabetics, the 
abnormal HRV is probably secondary to the metabolic 
derangements of diabetes, decreased capillary 
perfusion, and hypercoagulability within autonomic 
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nerves and the myocardium, which may be associated 
with or lead to elevated cholesterol levels [38]. 
Age of patients (β = - 3.2, 95% CI: -5.4 – 1.0, 
p = 0.006) and QTc (β = -0.1, 95% CI: -0.2 - -0.003, p 
= 0.04) were related to SDARR by stepwise multiple 
regression analysis. On the other hand, Duration of 
disease (β = - 1.5, 95% CI: -2.6 - -0.4, p=0.01) and (β 
= -1.7, 95% CI: - 2.9 – - 0.4, p = 0.008) and HbA1 (β = 
-2.2, 95% CI: -4.0 - -0.5, p = 0.01) and (β = -2.5, 95% 
CI: -4.4 - -0.7, p = 0.009) were related to SDRR and 
RMSSD by stepwise multiple regression analysis 
respectively. DRR was related to VLDL (β = - 0.9, 
95% CI: - 0.4 – 1.3, p = 0.002) and HbA1 (β = -2.2, 
95% CI: -4.3 – 0.1, p = 0.04). On the contrary, 
duration of disease (β = -1.1, 95% CI: -1.8 - -0.3, p = 
0.008) was the only parameter related to PNN50 by 
stepwise multiple regression analysis. This coincide 
with previous studies which demonstrated 
associations between reduced HRV and older age, 
extended disease duration (DD), higher HbA1, 
elevated albuminuria, higher fibrinogen, and increased 
CAC volume at baseline in T1D subjects [39, 40]. 
CAN in diabetes is thought to occur at least in part 
due to the effect of hyperglycemia through the 
accumulation of reduced sugars in diabetic nerves. 
The neuropathogenic effect may then be triggered by 
hyperosmolarity, a change in the reductive–oxidative 
state, reduced nitric oxide synthesis, or vascular 
dysfunction [41]. 
The QT interval represents the time required 
for completion of both ventricular depolarization and 
repolarization and has been a parameter of particular 
interest [42]. This interval is equivalent to the 
ventricular refractory period as an indicator reflecting 
myocardial depolarization and repolarization, and is 
affected by chronotropic changes [43]. Moreover, 
because the QTc interval duration was related with 
sympathetic overactivity, QTc prolongation could be 
an expression of the impaired autonomic activity that 
characterizes the insulin-resistant subjects with 
impaired fasting glycaemia and impaired glucose 
tolerance [43]. 
No significant difference of demographic and 
anthropometric data, blood pressure, and lipid profile 
was found in diabetic patients in relation to CAC score 
(data not present). It may be related to the small 
number of positive cases, if the number of patients 
increases and we select patients with longer duration 
of disease, we can find more patients with positive 
CAC score and a significant difference could be 
found. In the contrary, Salem et al, [27] reported that 
diabetics with positive CAC had significantly elder 
age, longer duration and higher mean glycosylated 
hemoglobin, blood pressure, albumin/ creatinine ratio 
and serum lipids. 
Limitation of the study: Number of patients 
with positive CAC score is small. Urine morning 
sample is used for diagnosis of microalbuminuria as 
albumin is excreted in urine periodically. 
We conclude that Percentage of arrhythmia 
and positive CAC score was high in our patients. 
Diabetic patients had reduced HRV. Cardiac 
autonomic neuropathy is associated with older age, 
longer duration, and poor glycemic control and 
microalbuminuria.  
We recommend frequent follow up of 
asymptomatic diabetic patients for early diagnosis of 
CAN and subclinical cardiovascular disease by CAC 
score for early diagnosis and management of 
atherosclerosis. 
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